Vivus says impotence drug data good; shares rise

CHICAGO (Reuters) - An experimental impotence drug being developed by Vivus Inc. showed promise in promoting sex in a mid-stage clinical trial, the company said on Thursday, pushing shares up 12 percent in premarket trading.

Continue to Vivus says impotence drug data good; shares rise on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz